With the increasing scrutiny on drug safety and efficacy, understanding impurities is more important than ever and ever evolving guidelines are not aiding the efforts. To address those lacunas, Eminence has come up with 3rd Annual Pharma Impurity Con
With patient safety becoming more critical than ever in today's evolving healthcare landscape, the demand for robust drug safety practices continues to surge. After several successful editions in India and Dubai, Eminence Group returns with 4th Editi
A promising therapeutic option has been proposed at the Jawaharlal Nehru Centre for Advanced Scientific Research for treating...
Cipla made significant progress after obtaining USFDA permission for marketing its generic cancer drug. The USFDA granted Cipla authorization to introduce their paclitaxel protein-bound particles for injectable suspension (albumin-bound) under the br
Researchers believe that they have unearthed a fresh genetic cause of neurodevelopmental disorders that have never before...
.png)
The Drug Administration Department of Karnataka has withdrawn defective medications totaling Rs 24.3 lakh from the market as part of a campaign against subpar pharmaceuticals.
Novartis is launching its latest investment initiative shortly after President Donald Trump introduced sweeping new tariffs on...
Natco Pharma announced that its generic Risdiplam will launch at Rs 15,900 per bottle, which might be a transformative moment for treating rare diseases in India. Roche's Evrysdi, marketed for spinal muscular atrophy (SMA) treatment, reaches Rs. 6.2
Novo Nordisk has made the complete SOUL results presentation today, the results from a 3-phase cardiovascular outcomes study indicated that oral semaglutide significantly decreased the risk of major adverse cardiovascular events in adults with...
Medical Record Summarization agent, powered by generative AI and launched by UiPath, a global leader in enterprise automation and AI software, at Google Cloud Next 2025, were developed by...
, CDSCO.jpg)
